The government of India has been supporting States and UTs in procuring drugs and diagnostics for COVID19 management through a “Whole of Government” approach. The States and UTs are proactively supported by the Union Government for ensuring adequate availability of various medicines, medical equipment, PPE kits, masks etc., since April 2020.
In recent days, several States and UTs have reported an increasing number of patients suffering from COVID complications in the form of Mucormycosis, popularly known as Black Fungus. There is also a reported shortage of Amphotericin-B, an anti-fungal drug used for the treatment of the Black Fungus disease.
Union Ministry of Health along with the Dept. of Pharmaceuticals and Ministry of External Affairs (MEA) are making proactive efforts for significantly ramping up domestic production of Amphotericin-B drug. The Union Government has also made effective efforts in supplementing the domestic availability through securing supply from global manufactures